| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 127334-22-9 | Chol-2-eno[2,3-d]isoxazole(9CI); 1H-Cyclopenta[7,8]phenanthrol[3,2-d]isoxazole,chol-2-eno[2,3-d]isoxazole deriv.; 1H-Cyclopenta[7,8]phenanthro[3,2-d]isoxazole, 2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-tetradecahydro-10a,12a-dimethyl-1-(1-methylbutyl)-,[1R-[1a(R*),3ab,3ba,10aa,10bb,12aa]]-; [1R-[1a(R*),3ab,3ba,10aa,10bb,12aa]]-2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-Tetradecahydro-10a,12a-dimethyl-1-(1-methylbutyl)-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazole |  | C25H39NO | 詳情 | 供應(yīng)商 | |
| 2780-93-0 | 2(1H)-Quinolinone,6-methyl-4-pentadecyl-; 2(1H)-Quinolone,6-methyl-4-pentadecyl- (8CI); Carbostyril, 6-methyl-4-pentadecyl- (7CI); NSC119947 |  | C25H39NO | 詳情 | 供應(yīng)商 | |
| 123853-65-6 | 9,19-Cyclopregn-2-en-1-one,4,4,14-trimethyl-20-(methylamino)-, (5a,20S)-; Cyclobuxoviramine |  | C25H39NO | 詳情 | 供應(yīng)商 | |
| 100477-90-5 | 9,19-Cyclopregn-1-en-3-one,4,4,14-trimethyl-20-(methylamino)-, (5a,20S)- (9CI); 3H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene,9,19-cyclopregn-1-en-3-one deriv.; (-)-Cyclobuxoviricine; Cyclobuxoviricine; N-Demethylcyclobuxoviridine L |  | C25H39NO | 詳情 | 供應(yīng)商 | |
| 1053-21-0 | 9,19-Cyclopregn-17(20)-en-16-one,4,4,14-trimethyl-3-(methylamino)-, (3b,5a,17E)-; 9,19-Cyclo-5a,9b-pregn-17(20)-en-16-one,4,4,14-trimethyl-3b-(methylamino)-, (E)- (8CI); Cyclobuxophyllinine (7CI); 16H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene,9,19-cyclopregn-17(20)-en-16-one deriv.; (-)-(E)-Buxenone; (E)-Buxenone; Buxenone; Buxenone M; Cyclobuxophyllinine M |  | C25H39NO | 詳情 | 供應(yīng)商 | |
| 10088-22-9 | 9,19-Cyclopregn-17(20)-en-16-one,3-(dimethylamino)-4,14-dimethyl-, (3b,4a,5a,17E)-; 9,19-Cyclo-5a,9b-pregn-17(20)-en-16-one, 3b-(dimethylamino)-4a,14-dimethyl- (7CI,8CI); Cyclobuxosuffrine; Cyclobuxosuffrine K |  | C25H39NO | 詳情 | 供應(yīng)商 |